|
Negative effects
|
Medical users (N=180)
|
Misusers (N=245)
|
p-valueb
|
|---|
| |
n (%)
|
95%CI†
|
n (%)
|
95%CI
a
| |
|---|
|
Sleep disorders
|
103 (57.2)
|
49.6-64.6
|
142 (58.0)
|
51.5-64.2
|
0.9
|
|
Palpitations
|
70 (38.9)
|
31.7-46.4
|
131 (53.8)
|
47.0-59.8
|
0.003
|
|
Emotional instability
|
84 (46.7)
|
39.2-54.2
|
105 (42.9)
|
36.6-49.3
|
0.4
|
|
Agitation
|
47 (26.1)
|
19.9-33.2
|
93 (38.0)
|
31.9-44.4
|
0.01
|
|
Aggressiveness
|
54 (30.0)
|
23.4-37.3
|
71 (29.0)
|
23.4-35.1
|
0.8
|
|
Headaches
|
33 (18.3)
|
13.0-24.8
|
73 (29.8)
|
24.1-35.9
|
0.007
|
|
Depression
|
62 (34.4)
|
27.5-41.9
|
57 (23.3)
|
18.1-29.1
|
0.01
|
|
Nausea
|
47 (26.1)
|
19.9-33.2
|
40 (16.3)
|
11.9-21.6
|
0.01
|
|
Anorexia
|
51 (28.3)
|
21.8-35.5
|
39 (15.9)
|
11.6-21.1
|
0.002
|
|
Suicidal thoughts
|
26 (14.4)
|
9.7-20.4
|
27 (11.0)
|
7.4-15.6
|
0.3
|
|
Hallucinations
|
9 (5.0)
|
2.3-9.3
|
12 (4.9)
|
2.6-8.4
|
>0.9
|
|
Other
|
33 (18.3)
|
13.0-24.8
|
28 (11.4)
|
7.7-16.1
|
0.04
|
- a95%CI: Clopper-Pearson confidence interval
- bChi-square test
